Conformation of desmopressin, an analogue of the peptide hormone vasopressin, in aqueous solution as determined by NMR spectroscopy

European Journal of Biochemistry

Volumn 252, Issue 3, 1998, Pages 428-440

  Walse, Björn ^a   Kihlberg, Jan ^b   Drakenberg, Torbjörn ^a  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Desmopressin; NMR; Peptide conformation; Structure calculation; Time averaged restraint

Indexed keywords

DESMOPRESSIN; NEUROPHYSIN; OXYTOCIN;

ARTICLE; CALCULATION; CRYSTAL STRUCTURE; NEUROHYPOPHYSIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; VASOPRESSIN BLOOD LEVEL;

EID: 0032521667     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2520428.x     Document Type: Article

References (76)

1. Andersen, N. H., Neidigh, J. W., Harris, S. M., Lee, G. M., Liu, Z. & Tong, H. (1997) Extracting information from the temperature gradients of polypeptide NH chemical shifts. 1. The importance of conformational averaging, J. Am. Chem. Soc. 119, 8547-8561.
2. Aue, W. P., Bartholdi, E. & Ernst, R. R. (1976) Two-dimensional spectroscopy. Application to nuclear magnetic resonance, J. Chem. Phys. 64, 2229-2246.
3. Bax, A. & Davis, D. G. (1985) Practical aspects of two-dimensional transverse NOE spectroscopy, J. Magn. Reson. 63, 207-213.
4. 1H chemical shifts in proteins, J. Biomol. NMR 9, 359-369.
5. Bodenhausen, G. & Ruhen, D. J. (1980) Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy, Chem. Phys. Lett. 69, 185-189.
6. Bodkin, M. J. & Goodfellow, J. M. (1996) Hydrophobic solvation in aqueous trifluoroethanol solution. Biopolymers 39, 43-50.
7. Bothner-By, A. A., Stephens, R. L., Lee, J.-M. Warren, C. D. & Jeanloz, R. W. (1984) Structure determination of a tetrasaccharide: Transient nuclear Overhauser effects in the rotating frame, J. Am. Chem. Soc. 106, 811-813.
8. Braunschweiler, L. & Ernst, R. R. (1983) Coherence transfer by isotropic mixing: Application to correlation spectroscopy, J. Magn. Reson. 53, 521-528.
9. Breslow, E., Sardana, V. Deeb, R., Barbar, E. & Peyton, D. H. (1995) NMR behavior of the aromatic protons of bovine neurophysin-1 and its peptide complexes: Implications for solution structure and for function. Biochemistry 34, 2137-2147.
10. Brünger, A. T. (1992) X-PLOR, Version 3.1. A system for X-ray crystallography and NMR, Yale University Press, New Haven CT.
11. Cammers-Goodwin, A., Allen, T. J., Oslick, S. L., McClure, K. F., Lee, J. H. & Kemp, D. S. (1996) Mechanism of stabilization of helical conformations of polypeptides by water containing trifluoroethanol, J. Am. Chem. Soc. 118, 3082-3090.
12. Cash, J. D., Gader, A. M. A. & Costa, J. D. (1974) The release of plasminogen activator and factor VIII by LVP, AVP, desmopressin AT III and OT in man, Br. J. Haematol. 27, 363-364.
13. du Vigneaud, V., Lawler, H. C. & Popenoe, E. A. (1953) Enzymatic cleavage of glycinamide from vasopressin and a proposed structure for this pressor-antidiuretic hormone of the posterior pituitary, J. Am. Chem. Soc: 75, 4880-4881.
14. du Vigneaud, V. Gish, D. T., Katsoyannis, P. G. & Hess, G. P. (1958) Synthesis of the pressor-antidiuretic hormone, arginine-vasopressin, J. Am. Chem. Soc. 80, 3355-3358.
15. Dyson, H. J. & Wright, P. E. (1991) Defining solution conformations of small linear peptides, Annu. Rev. Biophys. Chem. 20, 519-538.
16. Ferrin, T. E., Huang, C. C., Jarvis, L. E. & Langridge, R. (1988) The MIDAS display system, J. Mol. Graphics 6, 13-27.
17. Guarnieri, F. & Weinstein, H. (1996) Conformational memories and the exploration of biologically relevant peptide conformations: An illustration for the gonadotropin-releasing hormone, J. Am. Chem. Soc. 118, 5580-5589.
18. Hempel, J. C. (1987) The conformation of neurohypophyseal hormones, in The peptides: Analysis, synthesis, biology (Smith, C. W., ed.) vol. 8, pp. 209-237, Academic Press, New York.
19. Hruby, V. J. & Lebl, M. (1987) I. Conformational properties of neurohypophyseal hormone analogs in solution as determined by NMR and laser Raman spectroscopies, in CRC Handbook of neurohypophyseal hormone analogs (Jost, K., Lebl, M. & Brtnik, F., eds) vol. 1, pp. 105-155, CRC Press, Boca Raton FL.
20. Hruby, V. J. & Smith, C. W. (1987) Structure-activity relationships of the neurohypophyseal peptides, in The peptides: Analysis, synthesis, biology (Smith, C. W., ed.) vol. 8, pp. 77-207, Academic Press, New York.
21. Husain, J., Blundell, T. J., Cooper, S., Pitts, J. E., Tickle, I. J., Wood, S. P., Hruby, V. J., Buku, A., Fischman, A. J., Wyssbrod, H. R. & Mascarenhas, Y. (1990) The conformation of deamino oxytocin: X-ray analysis of the 'dry' and 'wet' forms, Phil. Trans. R. Soc. Lond. B 327, 625-654.
22. Kato, T., Endo, S., Fujiwara, T. & Nagayama, K. (1993) Oxytocin solution structures changes upon protonation of the N-terminus in dimethyl sulfoxide, J. Biomol. NMR 3, 653-673.
23. Kessler, H., Griesinger, C., Lautz, J., Müller, A., van Gunsteren, W. F. & Berendsen, H. J. C. (1988) Conformational dynamics detected by nuclear magnetic resonance NOE values and J coupling constants, J. Am. Chem. Soc. 110, 3393-3396.
24. Kihlberg, J., Åhman, J., Walse, B., Drakenberg, T., Nilsson, A., Söderberg-Ahlm, C., Bengtsson, B. & Olsson, H. (1995) Glycosylated peptide hormones: Pharmacological properties and conformational studies of analogues of [1-desamino, 8-D-arginine]vasopressin, J. Med. Chem. 38, 161-169.
25. Langs, D. A., Smith, G. D., Stezowski, J. J. & Hughes, R. E. (1986) Structure of pressinoic acid: The cyclic moiety of vasopressin, Science 232, 1240-1242.
26. Larive, C. K., Guerra, L. & Rabenstein, D. L. (1992) Cis/trans conformational equilibrium across the cysteine6-proline peptide bond of oxytocin, arginine vasopressin, and lysine vasopressin, J. Am. Chem. Soc. 114, 7331-7337.
27. Larive, C. K. & Rabenstein, D. L. (1993) Dynamics of Cis/trans isomerization of the cysteine6-proline peptide bonds of oxytocin and arginine-vasopressin in aqueous and methanol solutions, J. Am. Chem. Soc: 115, 2833-2836.
28. Lippens, G., Hallenga, K., van Belle, D., Wodak, S. J., Nirmala, N. R., Hill, P., Russell, K. C., Smith, D. D. & Hruby, V. J. (1993) Transfer nuclear Overhauser effect study of the conformation of oxytocin bound to bovine neurophysin I, Biochemistry 32, 9423-9434.
29. Liwo, A., Tempczyk, A., Oldziej, S., Shenderovich, M. D., Hruby, V. J., Talluri, S., Ciarkowski, J., Kasprzykowski, F., Lankiewicz, L. & Grzonka, Z. (1995) Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methods, Biopolymers 38, 157-175.
30. Manning, M., Bankowski, K. & Sawyer, W. H. (1987) Selective agonists and antagonists of vasopressin, in Vasopressin; Principles and properties (Gash, D. M. & Boer, G. J., eds) pp. 335-368, Plenum, New York.
31. Mannucci, P. M., Åberg, M., Nilsson, I. M. & Robertsson, B. (1975) Mechanism of Plasminogen activator and factor VIII increase after vasoactive drugs, Br. J. Haematol. 30, 81-93.
32. Marion, D., Ikura, M. & Bax, A. (1989) Improved solvent suppression in one- and two-dimensional NMR spectra by convolution of time-domain data, J. Magn. Reson. 84, 425-430.
33. Meraldi, J.-P. Hruby, V. J. & Brewster, A. I. R. (1977) Relative conformational rigidity in oxytocin and [1-penicillamine]-oxytocin: A proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism, Proc. Natl Acad. Sci. USA 74, 1373-1377.
34. 1H chemical shifts obtained as a function of temperature and trifluorethanol concentration for the peptide series GGXGG, J. Biomol. NMR 5, 14-27.
35. Mosberg, H. I., Hruby, V. J. & Meraldi, J.-P. (1981) Conformational study of the potent peptide hormone antagonist [1-penicillamine, 2-leucine]oxytocin in aqueous solution, Biochemistry 20, 2822-2828.
36. Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S. & Barberis, C. (1995) The binding site of neuropeptide vasopressin Via receptor. Evidence for a major localization within transmembrane regions, J. Biol. Chem. 270, 25 771-25 777.
37. Nanzer, A. P., van Gunsteren, W. F. & Torda, A. E. (1995) Parametrisation of time-averaged distance restraints in MD simulations, J. Biomol. NMR 6, 313-320.
38. Neuhaus, D. & Williamson, M. (1989) The nuclear Overhauser effect in structural and conformational analysis, VCH Publishers, New York.
39. 1H NMR spectroscopic and molecular dynamics study, Magn. Reson. Chem. 31, 481-488.
40. Ohnishi, M. & Urry, D. W. (1969) Temperature dependence of amide proton chemical shifts: The secondary structures of gramicidin S and valinomycin, Biochem. Biophys. Res. Commun. 36, 194-202.
41. Perlman, D. A. (1994) How is an NMR structure best defined? An analysis of molecular dynamics distance-based approaches, J. Biomol. NMR 4, 1-16.
42. Petsko, G. A. (1996) Not just your average structures, Nat. Struct. Biol. 3, 565-566.
43. Polshakov, V. I., Frenkiel, T. A., Birdsall, B., Soteriou, A. & Feeney, J. (1995) Determination of stereospecific assignments, torsion-angle constraints, and rotamer populations in proteins using the program AngleSearch, J. Magn. Reson. B 108, 31-43.
44. Rance, M. (1987) Improved techniques for homonuclear rotating-frame and isotropic mixing experiments, J. Magn. Reson. 74, 557-564.
45. Rose, G. D., Gierasch, L. M. & Smith, J. A. (1985) Turns in peptides and proteins, Adv. Protein Chem. 37, 1-109.
46. Rose, J. P., Wu, C.-K., Hsiao, C.-D., Breslow, E. & Wang, B.-C. (1996) Crystal structure of the neurophysin-oxytocin complex, Nat. Struct. Biol. 3, 163-169.
47. Rothemund, S., Weisshoff, H., Beyermann, M., Bienen, M., Mügge, C., Sykes, B. D. & Sönnichsen, F. D. (1996) Temperature coefficints of amide proton NMR resonance frequencies in trifluorocthanol: A monitor of intramolecular hydrogen bonds in helical peptides? J. Biomol. NMR 8, 93-97.
48. Schmidt, J. M., Ohlenschläger, O., Rüterjans, H., Grzonka, Z., Kojro, E., Pavo, I. & Fahrenholz, F. (1991) Conformation of [8-arginine]va-sopressin and V1 antagonists in dimetyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation, Eur. J. Biochem. 201, 355-371.
49. Shaka, A. J., Barker, P. B. & Freeman, R. (1985) Computer-optimized decoupling scheme for wideband applications and low-level operation, J. Magn. Reson. 64, 547-552.
50. Shaka, A. J., Lee, C. J. & Pines, A. (1988) Iterative schemes for bilinear operators; Application to spin decoupling, J. Magn. Reson. 77, 274-293.
51. Shenderovich, M. D., Sekacis, I. P., Liepinsh, E. E., Nikiforovich, G. V. & Papsuevich, O. S. (1985) Investigation of the spatial structure of des-Gly9-[Arg8]vasopressin by the methods of two-dimensional NMR spectroscopy and theoretical conformational analysis, Soviet J. Bioorg. Chem. 11, 632-642.
52. 1H-NMR spectroscopy and molecular mechanics calculations, Int. J. Peptide Protein Res. 38, 528-538.
53. Smith, L. J., Bolin, K. A., Schwalbe, H., MacArthur, M. W., Thornton, J. M. & Dobson, C. M. (1996) Analysis of main chain torsion angles in proteins: Prediction of NMR coupling constants for native and random coil conformations, J. Mol. Biol. 255, 494-506.
54. States, D. J., Haberkorn, R. A. & Ruhen, D. J. (1982) A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants, J. Magn. Reson. 48, 286-292.
55. Torda, A. E., Scheck, R. M. & van Gunsteren, W. F. (1989) Time-dependent distance restraints in molecular dynamics simulations, Chem. Phys. Lett. 157, 289-294.
56. Torda, A. E., Scheck, R. M. & van Gunsteren, W. F. (1990) Time-averaged nuclear Overhauser effect distance restraints applied to tendamistat, J. Mol. Biol. 214, 223-235.
57. Ufer, E., Postina, R., Gorbulev, V. & Fahrenholz, F. (1995) An extracellular residue determines the agonist specificity of V2 vasopressin receptors, FEBS Lett. 362, 19-23.
58. Vavra, I., Machova, A., Holecek, V., Cort, J. H., Zaoral, M. & Sorm, F. (1968) Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus, Lancet 1, 948-952.
59. Walter, R., Prasad, K. U. M., Deslauriers, R. & Smith, I. C. P. (1973) Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy, Proc. Natl Acad. Sci. USA 70, 2086-2090.
60. Walter, R., Ballardin, A., Schwartz, I. L., Gibbons, W. A. & Wyssbrod, H. R. (1974) Conformational studies on arginine vasopressin and arginine vasotocin by proton magnetic resonance spectroscopy, Proc. Natl Acad. Sci. USA 71, 4528-4532.
61. Walter, R. (1977) Identification of sites in oxytocin involved in uterine receptor recognition and activation, Fed. Proc. Am. Soc: Exp. Biol. 36, 1872-1878.
62. Wang, J., Hodges, R. S. & Sykes, B. D. (1995a) Effect of trifluoroethanol on the solution structure and flexibility of desmopressin: a two-dimensional NMR study, Int. J. Peptide Protein Res. 45, 471-481.
63. Wang, J., Hodges, R. S. & Sykes, B. D. (1995b) Generating multiple conformations of flexible peptides in solution based on NMR nuclear Overhauser effect data: Application to desmopressin, J. Am. Chem. Soc. 117, 8627-8634.
64. Wang, J., Breslow, E. & Sykes, B. D. (1996) Differential binding of desmopressin and vasopressin to neurophysin-II, J. Biol. Chem. 271, 31 354-31 359.
65. Williamson, M. P. & Waltho, J. P. (1992) Peptide Structure from NMR. Chem. Soc. Rev. 21, 227-236.
66. Wishart, D. S., Sykes, B. D. & Richards, F. M. (1992) The chemical shift index: A fast and simple method for the assignment of protein secondary structure through NMR spectroscopy, Biochemistry 31, 1647-1651.
67. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighhor effects, J. Biomol. NMR 5, 67-81.
68. Wood, S. P., Tickle, I. J., Treharne, A. M., Pitts, J. E., Mascarenhas, Y., Li, J. Y., Husain, J., Cooper, S., Blundell, T. L., Hruby, V. J., Bakub A., Fischman, A. J. & Wyssbrod, H. R. (1986) Crystal structure analysis of deamino-oxytocin: Conformational flexibility and receptor binding, Science 232, 633-636.
69. Wüthrich, K., Billeter, M. & Braun, W. (1983) Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance, J. Mol. Biol. 169, 949-961.
70. Wüthrich, K. (1986) NMR of Proteins and nucleic acids, John Wiley & Sons, New York.
71. Yip, P. F. (1990) Scaling NOESY Cross Peaks Involving Methyl Protons, J. Magn. Reson. 90, 382-383.
72. Yu, T., Yung, T.-H., Yeh, C.-J. & Chuang, L.-C. (1992) Combined use of NMR, distance geometry, and restrained energy minimization for the conformational analysis of 8-lysine-vasopressin, Can. J. Chem. 70, 1950-1955.
73. Zaoral, M. (1985) Vasopressin analogues with high and specific antidiuretic activity, Int. J. Peptide Protein Res. 25, 561-574.
74. Zaoral, M., Kole, J. & Sorm, F. (1967) Amino acids and peptides LXXI. Synthesis of 1-deamino-8-D-γ-aminobutyrine-vasopressin, 1-deamino-8-D-lysine-vasopressin, and 1-deamino-8-D-arginine-vasopressin, Coll. Czech. Chem. Commun. 32, 1250-1257.
75. Zieger, G., Andreae, F. & Sterk, H. (1991) Assignment of proton NMR resonances and conformational analysis of |Lys 8|-vasopressin homologues, Magn. Reson. Chem. 29, 580-586.
76. 1H NMR relaxation, Magn. Reson. Chem. 30, 387-392.